Tag Archives: Covance

Bruce L. Braaten, Regional Manager, Market Access, Covance

Bruce Braaten photoBruce currently serves as the Field Access and Reimbursement Director in the West Region. Mr. Braaten has over 20 years of experience in the biotech/device industry. Most recently he held positions with Roche serving in various leadership roles within the organization. Bruce brings experience as the Area Business Manager for the national Channel team for the purpose of building overall relationships, contract negotiations, securing coverage and reimbursement, and streamlining steps for smoother claims processing. He also held roles in leading field based teams, contracting with Managed Care Companies, sales leadership, project management and developing presentations for field use.

Bruce has a Bachelor’s Degree in Biology and has studied in areas of Healthcare administration, Healthcare policy, and Organizational Communication.

1. Why did you decide to do a webinar with Business Review Webinars?

This is an important opportunity to present and discuss our Market Access directives which support and improve Patient Health.

2. What are you looking forward to explaining to the audience?

Access is a challenging and a changing environment; however with the experience and overall knowledge of the market patients can receive the therapy their Health team prescribes they need.

3. How did you get into the industry and what do you most enjoy about your role?

My first experience in supporting patient access was on the medical device side for pain management. This confirmed in me how vital this type of role is and how strategy is crucial in care and coverage. My career has grown from Managed Care contracting; Distribution; patient support and sales leadership. My purpose in my work comes from the numerous successes of giving life back to individuals that are in great need and giving hope for a more fulfilling life.

4. What do you enjoy most about your role?

Currently my responsibilities include leading a team of Access Specialists in the West. This allows me the privilege of developing each individual with a greater skillset, to position our strategy for the purpose of patient care, and ultimately drive this ship in one direction.

5. Where is your favourite place in the world and why?

Today it is Arizona where my Wife and Children are. Spending time with them recharges me. If it was a particular place; it would have to be Northern Minnesota on the lake.

Register now for our webinar with Bruce and his colleagues from Covance, “The Yesterday and Today of Market Access: Field strategy evolution“.

Roshani Poudel, National Field Director, Market Access, Covance

Roshani Poudel_ PhotoRoshani Poudel has over 9 years of reimbursement and market access experience at Covance as well as with other Biotech/Pharmaceutical companies. During these 9 years, Roshani has developed reimbursement strategies during different phases of product life cycle that encompassed successful launch of multiple In-house/Contracted Hubs, Patient Assistance Programs , Field Reimbursement Teams and Marketing initiatives. Roshani has also led multiple Market Access efforts to remove significant coverage barriers with Medicare, Medicaid, and Commercial Payers for various “Buy and Bill” products.

As Director, Field Market Access at CMA, Roshani is responsible for developing and managing a group of Field Managers who oversee teams that conduct field-based site visits and customer training to remove any access barriers. Roshani also serves as a strategic partner for clients to implement new initiatives and ensures that they are aligned with the clients’ vision.

Roshani has a B. S. in Business Administration from Alliant International University, San Diego, CA.

1. Why did you decide to do a webinar with Business Review Webinars?

This is a great opportunity to discuss how Market Access strategy is crucial in providing patients access to the therapy they need.

2. What are you looking forward to explaining to the audience?

I look forward to sharing some real-life cases of access challenges that were presented to Covance Market Access and how we were able to provide solutions to those challenges.

3. How did you get into the industry and what do you most enjoy about your role?  

My first experience in the industry was with Covance 9 years ago when I was hired as a program specialist. My primary responsibility was working with patients that required financial assistance and helping them access their medications through several patient assistance and referral programs. It was an eye-opening experience to see the number of patients that needed financial support and yet had very limited knowledge of all the available resources for them. It was very rewarding to work with patients directly and being able to walk them through the process which ultimately allowed them to obtain their much needed medications. Some patients even took time to send personal thank you notes with their stories and how the medications had help change their lives positively, which was a satisfying aspect of the role in a personal level.

4. What do you enjoy most about your role?

I mostly enjoy the diversity of responsibilities in my current role that allows me to wear different hats on a daily basis. While I represent Covance and follow our own ideals, I am also learning and adapting to each of my client’s strategies and values which keeps me engaged. I also enjoy team development and talent management.

5. Where is your favourite place in the world and why?

Although I admire all historic cities around the world, Florence has to be on top on my list. From the narrow stone pavements that Da Vinci and Michelangelo once walked through to the distinctive architecture throughout the city, there is a reason why Florence is known as the “cradle of the Renaissance”.

Discuss “The Yesterday and Today of Market Access: Field strategy evolution” with Roshani in our webinar with Covance. Register now! 

William M. Fahey, National Field Director, Market Access, Covance

William Fahey_ PhotoWilliam works directly with the Field Managers and Field Reimbursement Specialists to ensure program
execution and strategic follow through based on client needs. In addition, he works as a strategic partner with the client to overcome hurdles and anticipate future opportunity specific to field team actions. He has directed teams within multiple therapeutic areas and lifecycle stages. 

Prior to joining Covance, Mr. Fahey has Over 15 years of experience in the pharmaceutical/biotech industry in various leadership roles within Sales, Sales Operations/Field Force Effectiveness, Marketing and Market Access. 

William has a BA in Philosophy/Political Science from the University of Arkansas.

1. Why did you decide to do a webinar with Business Review Webinars?

I believe it is important to connect as an industry in order to address complicated issues that impact the ability for patients to access appropriate therapies.

2. What are you looking forward to explaining to the audience?

I look forward to sharing opportunities that will address the above issues.  As access to therapies becomes more difficult, it is important to assess appropriate levers and partnerships that will potentially alleviate some of these market conditions and pressures for those involved.

3. How did you get into the industry and what do you most enjoy about your role?  

I spent several years both in sales and marketing within the tobacco industry.  This is what brought me into the healthcare sector.  Working on a daily basis and as a career on thoughts, processes and services that contribute to a person’s well-being is more rewarding than its polar opposite.

4. What do you enjoy most about your role?

Working with some of the top minds in the industry.  Learning and working on key issues that impact the industry on a daily basis provides a never-ending complexity that keeps a smile on my face.

5. Where is your favourite place in the world and why?

While I enjoy the comradery and engagement on a daily basis, I very much enjoy the solitude of the desert environment regardless of location.  I will typically take an annual motorcycle trip to various locations in which I get the chance to reflect and decompress from everything.

Join William in the upcoming Covance webinar “The Yesterday and Today of Market Access: Field strategy evolution“. Register now!

Peter M. Wahl, ScD, MLA, MS, Director, Epidemiology, Covance


Dr. Wahl is a pharmPeter M. Wahlacoepidemiologist specializing in complex study design and analytic methods, with expertise in the full spectrum of primary and secondary health care data. He directs epidemiological study design and advanced analytics in Covance Market Access Services, and devises strategic advice for clients in the development and synthesis of real world evidence. 

For the past 20 years, Dr. Wahl has held management, consulting, and research positions in for-profit and academic institutions including Aetion, the Division of Pharmacoepidemiology & Pharmacoeconomics in the Department of Medicine at the Brigham & Women’s Hospital and Harvard Medical School, HealthCore, the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania School of Medicine, CareScience, and the Division of Cardiothoracic Surgery at the Hospital of the University of Pennsylvania. 

Dr. Wahl received his ScD in Epidemiology from the Harvard School of Public Health, his MS from the University of Pennsylvania School of Medicine, and his MLA from the University of Pennsylvania. He received his training in Pharmacoepidemiology in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and Harvard Medical School. Dr. Wahl also holds a BA in Economics from Cornell University.


  1. Why did you decide to do a webinar with us?

The importance of real-world evidence for healthcare decision-making has grown rapidly in the past decade, making it critical to understand its applications.  Given our expertise in the nuances of real-world data and their individual strengths and challenges, we want to share this knowledge in the hope that well-informed colleagues can become effective stewards of meaningful, actionable real-world evidence.

  1. What will the audience gain from attending your webinar?

Attendees will acquire foundational knowledge and a framework to begin meaningful dialogs with their internal stakeholders around real-world evidence and the value it can bring to their organization. Specifically, the audience will become familiar with:

  • The continuum of healthcare evidence
  • Real-world evidence throughout the product development life-cycle
  • Strengths and limitations of available real-world data sources
  • A decision-analytic framework for real-world evidence development
  • Resources for best practices
  1. What’s your favourite thing about presenting to a live audience?

Presenting live offers an opportunity to engage with the audience.  The question and answer period is an excellent time to get feedback on what has been on people’s minds during the presentation, as well as to find out what most vexes them with regard to the topic at hand.  Providing meaningful answers to these questions is an opportunity to put the icing on the cake.

  1. Who or what inspired you to get into the industry?

I was working in the Division of Cardiothoracic Surgery at the University of Pennsylvania in the mid-90s, coordinating the observational clinical research program for the surgical head of the lung transplant and aortic arch surgery programs.  We needed someone to perform the necessary statistical tests for comparisons of treatment outcomes, so I began teaching myself using Excel and textbooks.  When the Division started loaning me out to the Cardiology and Pulmonary Care divisions, I realized I needed more formal training, and got hooked on the Epidemiology courses at the Center for Clinical Epidemiology and Biostatistics.  Those courses led to one master’s degree, then another. After working in both academia as well as the private sector, I eventually completed my doctoral degree in Epidemiology at the Harvard School of Public Health and my training in Pharmacoepidemiology at the Brigham.

  1. What one item would you take with you to a desert island?

Do pen and paper count as one item?  I am a book-aholic and my hobby is writing, so I would want something to write down my thoughts—or perhaps an adventure story about a pharmacoepidemiologist who escapes from a desert island.  I would write as much as possible…at least until the pen runs out and the papers blow away in a tropical storm.

Covance will be presenting their webinar Generating Real-world Evidence with Healthcare Data on 21st October at 1pm New York/6pm London Read more and register here.

John Giles, Jr., Director, Covance Market Access Services

John GilesJohn is a Director in Managed Market Services and leads the business development in Covance Managed Market Services business. He has been in various roles for 25 years in the healthcare industry, specializing in a wide variety of data solutions, account management, analytics and enterprise wide systems. 

He has worked for Roche and Johnson & Johnson in sales and marketing, contracting and sales operations. Before joining Covance, John was an Account Executive for IMS Health selling the portfolio of products and services. At IMS Health, John worked closely with Fortune 50 companies to help create marketing strategies and create solutions to wide variety of issues.

1. Why did you decide to do a webinar with us?

BRW is the gold standard of webinar vendors.

2. What will the audience gain from attending your webinar?

A better understanding of the 340B Program as it continues to evolve and raise concerns.

3. How did you get into the industry and what do you most enjoy about your role?

I started in the pharma industry in 1991 with Roche as a sales rep, then moved into management in sales operations in various roles on both sides , manufacturing and vendor.  What I enjoy most about my role is guiding clients through the complex healthcare issues that exist and continue to grow even more complex.

4. What are you hoping to achieve in the future in your personal and professional life?

To continue to be a constant learner. Life and the market are always evolving. I want to continue to identify the patterns and trends and stay current with the technology as the healthcare system undergoes rapid transformation.

5. What would someone be surprised to know about you? 

I have been skydiving and scuba diving.

John will be presenting Covance’s webinar ‘Challenges of Complying with 340B Program‘ with Steve Madina, Vice President, Covance Market Access Services on the 30th April at 1pm New York/6pm London. You can register for the webinar here


The Affordable Care Act – Who Has It Helped The Most?

CovancePicA new data set has been published that paints a clear picture of who gained insurance coverage during the 2014 open enrollment period, which ended on April 15, 2014.  Recently featured in the New York Times, the data come from Enroll America, a non-profit organization focused on enrolling Americans in health insurance plans, and Civis Analytics, a data analysis firm.

This data set provides insight into the 10 million previously uninsured individuals who now have health insurance.  Overall, these newly-insured people reduced the national uninsured rate for adults under the age of 65 from 16.3% in 2013 to 11.4% in 2014.

In addition, a number of criteria were analyzed, including:

  • Medicaid Expansion
    When the Supreme Court ruled in 2012 that Medicaid expansion was optional, the high court helped determine one of the main criteria for who would benefit from these reforms.  States that expanded their Medicaid programs realized greater reductions in their uninsured rates, dropping from 14.4% to 9.2%, compared to states that did not expand, which dropped from 18.2% to 13.8%.
  • Race
    Though black and Hispanic individuals remain uninsured at higher rates than their white and Asian peers, the former two groups have shown greater reduction in their rates of uninsurance over the past year.  The Hispanic uninsured rate dropped from 26.2% to 16.5%; the black uninsured rate dropped from 24.1% to 16.1%; the white uninsured rate dropped from 14.1% to 10%; and the Asian uninsured rate dropped from 13.6% to 9.7%.
  • Age
    Young adults were identified as a key group for insurers to enroll to prevent premium spikes caused by older and sicker individuals overpopulating the insurance pools; the data indicate that the young adult group witnessed the greatest drop in their uninsured rate.  The 18-34 age group decreased from 21.6% to 14.2%; the 35-44 age group decreased from 16.4% to 11.2%; the 45-54 age group decreased from 15% to 10.5%; and the 55-64 age group decreased from 12.7% to 9.1%.
  • Neighborhood Income
    With certain states raising Medicaid eligibility limits and the federal government providing subsidies for low-income individuals purchasing health insurance through the exchanges, the data show how the law has helped achieve one of its intended goals.  People from low-income neighborhoods witnessed the most significant increase in their insured rates.  The lowest income quintile dropped from 26.4% to 17.5%; the second lowest income quintile dropped from 21.6% to 14.3%; the middle income quintile dropped from 17.5% to 11.9%; the second highest income quintile dropped from 13.4% to 9.4%; and the highest income quintile dropped from 8.2% to 6.5%.
  • Gender
    Even before the Affordable Care Act was implemented, women were more likely to have insurance than men.  This gender gap only increased since the reforms took effect in January 2014, as the uninsurance rate among women dropped from 15.3% to 9.8%, compared to the uninsurance rate among men, which dropped from 17.7% to 13%.
  • County Political Leanings
    Interestingly, areas in the country with Republican leanings saw a greater uptick in insurance rates than those with Democratic leanings.  This may be partly explained by the geographic distribution of wealth in the nation and the fact that many liberal-leaning states (such as Massachusetts) already had initiatives in place to provide access to healthcare for low-income individuals.  This trend is also evidence that traditionally Republican-leaning states that embraced Affordable Care Act reforms (such as Kentucky and Arkansas) were successful in reducing the uninsurance rates in their states.  Overall, the uninsurance rates in counties that traditionally voted Republican dropped from 18.5% to 13.1%, while the rates in in counties that traditionally voted Democrat dropped from 12% to 8.8%.
  • Urban vs. Rural
    Individuals living in rural areas and smaller cities were more likely to gain insurance during the 2014 open enrollment period than individuals living in big cities, who generally were more likely to have health insurance in the first place.  The uninsurance rates for individuals living in rural settings dropped from 20% to 13.3%; the rates for individuals living in small cities dropped from 19% to 12.7%; and the rates for individuals living in larger cities dropped from 16% to 11.1%.

While this data provides a clearer picture of the Affordable Care Act’s impact on the uninsured in 2014, uncertainty remains regarding its impact in the coming year.  The 2015 open enrollment period will present a set of challenges unlike 2014, such as having an enrollment period that is 2 months shorter than 2014, likely less media attention, and a smaller uninsured pool from which to recruit.  Further, certain individuals may decide that purchasing health insurance for another year is not a wise investment due to unexpectedly high out-of-pocket costs and opt not to re-enroll.  Finally, the landscape of Medicaid expansion will likely evolve in the coming year, with a number of states (such as Utah and Indiana) in negotiation with the federal government on terms to expand, while other states could potentially move away from this expansion (namely, Arkansas).  Additionally, there is an increase in the overall amount of insurers participating in the Health Insurance Marketplace, as well as an anticipated decrease in premiums in exchange plans.

Though these variables create uncertainty for the Obama administration and industry stakeholders, the Enroll America/Civis data suggest that those most likely to be enrolled in the 2015 open enrollment period are those individuals who are least likely to have health insurance in the first place. This enrollment period will need to be monitored closely to see if these trends hold true for a second year running.

For more information visit http://www.covance.com/industry-solutions/healthcare/commercialization.html